The DOI matches its Crossref record; 242 of the 245 references it cites were found in a registry or an index, and 1 are not checked yet.
Neurodegenerative Tauopathies
Abstract
The defining neuropathological characteristics of Alzheimer's disease are abundant filamentous tau lesions and deposits of fibrillar amyloid beta peptides. Prominent filamentous tau inclusions and brain degeneration in the absence of beta-amyloid deposits are also hallmarks of neurodegenerative tauopathies exemplified by sporadic corticobasal degeneration, progressive supranuclear palsy, and Pick's disease, as well as by hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Because multiple tau gene mutations are pathogenic for FTDP-17 and tau polymorphisms appear to be genetic risk factors for sporadic progressive supranuclear palsy and corticobasal degeneration, tau abnormalities are linked directly to the etiology and pathogenesis of neurodegenerative disease. Indeed, emerging data support the hypothesis that different tau gene mutations are pathogenic because they impair tau functions, promote tau fibrillization, or perturb tau gene splicing, thereby leading to formation of biochemically and structurally distinct aggregates of tau. Nonetheless, different members of the same kindred often exhibit diverse FTDP-17 syndromes, which suggests that additional genetic or epigenetic factors influence the phenotypic manifestations of neurodegenerative tauopathies. Although these and other hypothetical mechanisms of neurodegenerative tauopathies remain to be tested and validated, transgenic models are increasingly available for this purpose, and they…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and a subset of frontotemporal dementia (FTD) are neurodegenerative disorders characterized by tau inclusions in neurons and glia (tauopathies).”
From Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia (2017) · cites this paper as [26]
In the citing paper
“Neurodegenerative tauopathies are characterized by progressive neuronal and glial accumulation in amyloid assemblies of tau protein (Lee et al., 2001).”
From Spontaneous pathology in PS19 tauopathy mice progresses via brain networks (2025) · cites this paper as Lee et al., 2001
In the citing paper
“In the absence of amyloid-beta, NFTs are also implicated in several other neurodegenerative diseases (frontotemporal dementia with parkinsonism, progressive supranuclear palsey, corticobasal degeneration), further supporting the role of tau in the dementing process (Lee et al., 2001).”
From In vivo imaging of tau pathology using multi-parametric quantitative MRI (2015) · cites this paper as Lee et al., 2001
In the citing paper
“Tauopathies include several neurodegenerative diseases such as Pick's disease and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17; reviewed in 1).”
Citations
Cites
Items 201–243 of 243
Singh, T. J., Zaidi, T., Grundke, I., & Iqbal, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01383-c · Cited by 86
Vermersh, P., Wattez, A., Delacourte, A., Robitaille, Y., Bernier, L., & Gauvreau, D. (1994) · Acta Neuropathologica · doi:10.1007/bf00293317 · Cited by 85
Direct genetic evidence for involvement of tau in progressive supranuclear palsy
Bennett, P., Bonifati, V., Bonuccelli, U., Colosimo, C., Mari, M. D., Fabbrini, G., Marconi, R., Meco, G., Nicholl, D. J., Stocchi, F., et al. (1998) · Neurology · doi:10.1212/wnl.51.4.982 · Cited by 85
A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
Yasuda, M., Kawamata, T., Komure, O., Kuno, S., D’Souza, I., Poorkaj, P., Kawai, J., Tanimukai, S., Yamamoto, Y., Hasegawa, H. H., et al. (1999) · Neurology · doi:10.1212/wnl.53.4.864 · Cited by 84
Quantitative neurohistological features of frontotemporal degeneration
Arnold, S. E., Han, L.-Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00173-1 · Cited by 82
Self-citationMissense tau mutations identified in FTDP-17 have a small effect on tau–microtubule interactions
Deture, M. A., Ko, L., Yen, S. H., Nacharaju, P., Easson, C., Lewis, J. M., van Slegtenhorst, M., Hutton, M. L., & Yen, S.-H. C. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02124-1 · Cited by 81
Matsumura, N., Yamazaki, T., & Ihara, Y. (1999) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65420-x · Cited by 81
The FTDP‐17‐Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules
Pérez, M., Lim, F., Arrasate, M., & Ávila, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742583.x · Cited by 80
Si, Z., Rauch, D., & Stoltzfus, C. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5404 · Cited by 80
Hall, G. F., Chu, B., Lee, G. S., & Yao, J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.8.1373 · Cited by 78
Schmidt, M. L., Huang, R. T. C., Martin, J. A., Henley, J., Mawal-Dewan, M., Hurtig, H. I., Lee, V. M. Y., & Trojanowski, J. Q. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199605000-00006 · Cited by 78
Self-citationDementia of Frontal Type and Dementias with Subcortical Gliosis
Mann, D. M. A. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00157.x · Cited by 78
Hall, G. F., Yao, J., & Lee, G. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4733 · Cited by 76
(1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02073.x · Cited by 75
Familial Multiple-System Tauopathy with Presenile Dementia Is Localized to Chromosome 17
Murrell, J. R., Koller, D. L., Foroud, T., Goedert, M., Spillantini, M. G., Edenberg, H. J., Farlow, M. R., & Ghetti, B. F. (1997) · The American Journal of Human Genetics · doi:10.1086/301594 · Cited by 74
Self-citationErshov, A. V., & Bazan, N. G. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000501)60:3 · Cited by 74
Tseng, H.-C., & Graves, D. J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9382 · Cited by 73
Rizzu, P., Joosse, M., Ravid, R., Hoogeveen, A., Kamphorst, W., van Swieten, J. V., Willemsen, R., & Heutink, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.3075 · Cited by 72
Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome
Roy, S., Datta, C. K., Hirano, A., Ghatak, N. R., & Zimmerman, H. M. (1974) · Acta Neuropathologica · doi:10.1007/bf00684775 · Cited by 65
Interaction of Neuronal Cdc2-like Protein Kinase with Microtubule-associated Protein Tau
Sobue, K., Agarwal-Mawal, A., Li, W., Sun, W., Miura, Y., & Paudel, H. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000784200 · Cited by 64
Molecular flexibility in microtubule proteins: proton nuclear magnetic resonance characterization
Woody, R. W., Clark, D. C., Roberts, G. C. K., Martin, S. R., & Bayley, P. M. (1983) · Biochemistry · doi:10.1021/bi00278a020 · Cited by 59
Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
Arima, K., Kowalska, A., Hasegawa, M., Mukoyama, M., Watanabe, R., Kawai, M., Takahashi, K., Iwatsubo, T., Tabira, T., & Sunohara, N. (2000) · Neurology · doi:10.1212/wnl.54.9.1787 · Cited by 59
Ezquerra, M., Pastor, P., Valldeoriola, F., Luis Molinuevo, J., Blesa, R., Tolosa, E., & Oliva, R. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00738-7 · Cited by 58
Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease
Lieberman, A. P., Trojanowski, J. Q., Lee, V. M. ‐., Balin, B. J., Ding, X., Greenberg, J., Morrison, D., Reivich, M., & Grossman, M. (1998) · Annals of Neurology · doi:10.1002/ana.410430218 · Cited by 54
Self-citationMatsumoto, S., Hirano, A., & Goto, S. (1990) · Neurology · doi:10.1212/wnl.40.6.975 · Cited by 53
Braak, E., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/s004010050124 · Cited by 53
Hulette, C. M., Pericak‐Vance, M. A., Roses, A. D., Schmechel, D. E., Yamaoka, L. H., Gaskell, P. C., Welsh-Bohmer, K. A., Crowther, R. A., & Spillantini, M. G. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199908000-00008 · Cited by 52
Fibrillogenesis of Tau: Insights from Tau Missense Mutations in FTDP‐17
Yen, S.-H. C., Hutton, M. L., Deture, M. A., Ko, L., & Nacharaju, P. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00551.x · Cited by 48
Phosphorylated tau can promote tubulin assembly
Tseng, H.-C., Lu, Q., Henderson, E., & Graves, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9503 · Cited by 48
The tau gene A0 allele and progressive supranuclear palsy
Hoenicka, J., Pérez, M., Pérez‐Tur, J., Barabash, A., de Godoy, M. F., Vidal, L., Astarloa, R., Ávila, J., Nygaard, T. G., & de Yébenes, J. G. (1999) · Neurology · doi:10.1212/wnl.53.6.1219 · Cited by 48
Takahashi, M., Tomizawa, K., Ishiguro, K., Takamatsu, M., Fujita, S. C., & Imahori, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041759.x · Cited by 42
Tolnay, M., Spillantini, M. G., Rizzini, C., Eccles, D., Lowe, J. S., & Ellison, D. H. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00109.x · Cited by 41
The tau mutation (val337met) disrupts cytoskeletal networks of microtubules
Arawaka, S., Usami, M., Sahara, N., Schellenberg, G. D., Lee, G. S., & Mori, H. (1999) · Neuroreport · doi:10.1097/00001756-199904060-00018 · Cited by 33
Bonifati, V., Joosse, M., Nicholl, D. J., Vanacore, N., Bennett, P. R., Rizzu, P., Fabbrini, G., Marconi, R., Colosimo, C., Locuratolo, N., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00669-2 · Cited by 28
Familial frontotemporal dementia with a P301L tau mutation in Japan
Kodama, K., Okada, S., Iseki, E., Kowalska, A., Tabira, T., Hosoi, N., Yamanouchi, N., Noda, S., Komatsu, N., Nakazato, M., et al. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00288-4 · Cited by 27
Abnormal microtubule packing in processes of SF9 cells expressing the FTDP‐17 V337M tau mutation
Frappier, T. F., Liang, N. S., Brown, K. R., Leung, C. L., Lynch, T., Liem, R. K. H., & Shelanski, M. L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00902-3 · Cited by 23
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Self-citationSperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
- Self-citation
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2
Research works printed but not linked: 19
- Arrasate M, 1997, Am. J. Pathol., 151, 1115
- Brion JP, 1985, Arch. Biol., 95, 229
- Feany MB, 1995, Am. J. Pathol., 146, 1388
- 10.1007/s004010050296 · DOI
- 10.1128/mcb.9.4.1381 · DOI
- Hong M, Trojanowski JQ, Lee VM-Y. 2000.Tau-based neurofibrillary lesions.InNeurodegenerative Dementias, ed. CM Clark, JQ Trojanowski, pp. 161–75. New York: McGraw Hill
- 10.1007/s004010050140 · DOI
- Ksiezak-Reding H, 1994, Am. J. Pathol., 145, 1496
- 10.1007/s004010050138 · DOI
- Pickering-Brown S, 2000, Ann. Neurol., 48, 806, 10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1 · DOI
- Rebeiz J, 1967, Trans. Am. Neurol. Assoc., 92, 23
- Rep. Work Group Frontotemporal Dementia Pick's Disease. 2001. Clinical and neuropathological diagnosis of frontotemporal dementias.Neurobiol. Aging.In press
- Shin RW, 1991, Lab. Invest., 64, 693
- Snow AD, 1990, Am. J. Pathol., 137, 1253
- 10.1002/1531-8249(200012)48:6<939::aid-ana17>3.3.co;2-t · DOI
- Trojanowski JQ, 1994, Am. J. Pathol., 144, 449
- 10.1007/s004010050126 · DOI
- Wilhelmsen KC, 1994, Am. J. Hum. Genet., 55, 1159
- Wilson DM, 1997, Am. J. Pathol., 150, 2181
Cited by
Sorted by citations
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Buckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862
Metadata
- Authors
- Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 2001-03
- Volume
- 24
- Issue
- 1
- Pages
- 1121-1159
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- OpenAlex
- W4230565756
- Semantic Scholar
- 8eb6355272daf41b8da72a5b18a4d8c67d8509cc
- Cited by
- 2,480
- References
- 245
- Citations by year
- 2026: 60 · 2025: 81 · 2024: 102 · 2023: 112 · 2022: 133 · 2021: 130 · 2020: 126 · 2019: 107 · 2018: 114 · 2017: 94 · 2016: 100 · 2015: 115 · 2014: 99 · 2013: 100 · 2012: 92
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- tau protein, tau gene mutations, FTDP-17, progressive supranuclear palsy, corticobasal degeneration, Pick's disease, Alzheimer's disease, tau fibrillization, genetic risk factors, transgenic animal models, neurodegeneration
- MeSH terms
- Animals, Brain, Brain Diseases, Dementia, Humans, Neurofibrillary Tangles, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review